4.4 Article

Computational Approaches for the Structure-Based Identification of Novel Inhibitors Targeting Nucleoid-Associated Proteins in Mycobacterium Tuberculosis

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosis

Jing Sui et al.

Summary: This article describes the epigenetic changes that occur in the pathogen Mycobacterium tuberculosis and its host during infection, including DNA methylation, histone modification, and microRNA. It summarizes the research progress in drug discovery and tuberculosis diagnosis, providing new ideas and strategies to combat drug-resistant tuberculosis.

PHARMACOLOGICAL RESEARCH (2022)

Review Microbiology

Mycobacterium tuberculosisextracellular vesicles: exploitation for vaccine technology and diagnostic methods

Roghayeh Mohammadzadeh et al.

Summary: Tuberculosis is a deadly epidemic disease caused by Mycobacterium tuberculosis, and issues such as multidrug resistance and extensively drug-resistant tuberculosis have made efficient vaccines and diagnostic biomarkers essential. Extracellular vesicles, with their various cargos, are recognized as promising tools for designing novel vaccines, diagnostic biomarkers, and drug delivery systems in the fight against TB.

CRITICAL REVIEWS IN MICROBIOLOGY (2021)

Review Pharmacology & Pharmacy

Neglected tropical diseases and infectious illnesses: potential targeted peptides employed as hits compounds in drug design

Joao Vitor Silva et al.

Summary: NTDs and infectious illnesses like malaria, tuberculosis, and Zika fever are major public health concerns in many countries, causing thousands of deaths per year. Targeted peptides are considered promising in designing new drugs due to their specific action and reduced toxicity. The pharmaceutical industry shows rising interest in these compounds, with many already approved by the FDA and over 300 in clinical trials.

JOURNAL OF DRUG TARGETING (2021)

Review Respiratory System

Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment

James A. Seddon et al.

Summary: The diagnosis and treatment of multidrug-resistant tuberculosis in children have historically been neglected, leading to a low proportion of diagnosed and treated cases. However, recent developments in diagnostic and therapeutic approaches have improved pediatric management. Further research and evidence-based practices are needed to enhance prevention and treatment strategies for children with MDR-TB.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

Review Respiratory System

Social determinants of tuberculosis: context, framework, and the way forward to ending TB in India

Anurag Bhargava et al.

Summary: The study found that social determinants play a significant role in the causation and outcomes of TB in India, indicating that a combination of enhanced biomedical and social interventions is necessary for TB elimination.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

Review Immunology

Pathology of TB/COVID-19 Co-Infection: The phantom menace

Gabriel Tassi Mousquer et al.

Summary: Tuberculosis and COVID-19 are the leading causes of death among infectious diseases, with co-infection potentially causing immune system imbalance and exacerbating disease progression. Understanding the interactions between Mycobacterium tuberculosis and SARS-CoV-2 is crucial for developing therapeutic strategies against co-infection.

TUBERCULOSIS (2021)

Article Biochemical Research Methods

Differential mass spectrometry-based proteome analyses unveil major regulatory hubs in rifamycin B production in Amycolatopsis mediterranei

Nirjara Singhvi et al.

Summary: This study revealed the mechanisms of rifamycin biosynthesis in Amycolatopsis mediterranei through genetic engineering, identifying regulatory hubs crucial for improving strain production of analogs/drugs. This contributes significantly to the knowledge in the field and can be useful for eradicating TB caused by rifampicin-resistant strains.

JOURNAL OF PROTEOMICS (2021)

Article Biochemical Research Methods

In Silico End-to-End Protein-Ligand Interaction Characterization Pipeline: The Case of SARS-CoV-2

Nicia Rosario-Ferreira et al.

Summary: This study introduced computational protocols for targeting the SARS-CoV-2 main protease, including uploading, visualizing, and managing three-dimensional structures, homology modeling, protein-ligand docking, virtual screening, and molecular dynamics simulations. These protocols offer important insights into addressing one of the biggest biological problems currently facing the world.

ACS SYNTHETIC BIOLOGY (2021)

Article Chemistry, Multidisciplinary

Exploration of potential inhibitors for tuberculosis via structure-based drug design, molecular docking, and molecular dynamics simulation studies

Sreerama Rajasekhar et al.

Summary: The study identified novel and potent benzimidazole molecules to combat drug resistance in tuberculosis through molecular docking and molecular dynamics simulations. Machine learning algorithm predicted the inhibitory behavior of the compounds against tuberculosis, suggesting the designed benzimidazoles could serve as effective antitubercular agents.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Contriving a chimeric polyvalent vaccine to prevent infections caused by herpes simplex virus (type-1 and type-2): an exploratory immunoinformatic approach

Mahmudul Hasan et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)

Review Biotechnology & Applied Microbiology

Interplay of Human Gut Microbiome in Health and Wellness

Nirjara Singhvi et al.

INDIAN JOURNAL OF MICROBIOLOGY (2020)

Review Biotechnology & Applied Microbiology

Computational tools for modern vaccine development

Sunita et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Review Genetics & Heredity

Chromosome organization in bacteria: mechanistic insights into genome structure and function

Remus T. Dame et al.

NATURE REVIEWS GENETICS (2020)

Article Infectious Diseases

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

Giovanni Battista Migliori et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Biochemical Research Methods

Proteomic characterization of Mycobacterium tuberculosis reveals potential targets of bostrycin

Peibo Yuan et al.

JOURNAL OF PROTEOMICS (2020)

Article Biochemistry & Molecular Biology

Gain of native conformation of Aurora A S155R mutant by small molecules

Garima Tanwar et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Review Integrative & Complementary Medicine

High content screening for drug discovery from traditional Chinese medicine

Jing Wang et al.

CHINESE MEDICINE (2019)

Article Biotechnology & Applied Microbiology

Investigating function roles of hypothetical proteins encoded by the Mycobacterium tuberculosis H37Rv genome

Zhiyuan Yang et al.

BMC GENOMICS (2019)

Review Immunology

Nucleoid-Associated Protein HU: A Lilliputian in Gene Regulation of Bacterial Virulence

Pavla Stojkova et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Review Pharmacology & Pharmacy

Advancing Drug Discovery via Artificial Intelligence

H. C. Stephen Chan et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Review Robotics

Advances and Perspectives in Applying Deep Learning for Drug Design and Discovery

Celio F. Lipinski et al.

FRONTIERS IN ROBOTICS AND AI (2019)

Article Biochemistry & Molecular Biology

DrugBank 5.0: a major update to the DrugBank database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Biochemistry & Molecular Biology

Molecular Visualization on the Holodeck

Thomas D. Goddard et al.

JOURNAL OF MOLECULAR BIOLOGY (2018)

Article Biochemistry & Molecular Biology

CASTp 3.0: computed atlas of surface topography of proteins

Wei Tian et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Infectious Diseases

Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy

Caroline M. Pule et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

Review Chemistry, Medicinal

Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB

Kavita Chaudhari et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Functional analysis of the binding model of microbial inulinases using docking and molecular dynamics simulation

Puneet Kumar Singh et al.

JOURNAL OF MOLECULAR MODELING (2016)

Article Microbiology

Zafirlukast Inhibits Complexation of Lsr2 with DNA and Growth of Mycobacterium tuberculosis

Lucile Pinault et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Biochemistry & Molecular Biology

A novel nucleoid-associated protein specific to the actinobacteria

Julia P. Swiercz et al.

NUCLEIC ACIDS RESEARCH (2013)

Review Multidisciplinary Sciences

Progress and challenges in translating the biology of atherosclerosis

Peter Libby et al.

NATURE (2011)

Article Chemistry, Multidisciplinary

Open Babel: An open chemical toolbox

Noel M. O'Boyle et al.

JOURNAL OF CHEMINFORMATICS (2011)

Review Pharmacology & Pharmacy

Immunoinformatics: Current trends and future directions

Joo Chuan Tong et al.

DRUG DISCOVERY TODAY (2009)

Article Biochemistry & Molecular Biology

A novel nucleoid-associated protein of Mycobacterium tuberculosis is a sequence homolog of GroEL

Debashree Basu et al.

NUCLEIC ACIDS RESEARCH (2009)

Article Biochemistry & Molecular Biology

ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins

Markus Wiederstein et al.

NUCLEIC ACIDS RESEARCH (2007)

Article Biochemistry & Molecular Biology

SWISS-MODEL: an automated protein homology-modeling server

T Schwede et al.

NUCLEIC ACIDS RESEARCH (2003)